AAAAAA

   
Results: 1-8 |
Results: 8
DNA fingerprinting of serial Candida albicans isolates obtained during itraconazole prophylaxis in patients with AIDS
Authors: Le Monte, AM Goldman, M Smedema, ML Connolly, PA McKinsey, DS Cloud, GA Kauffman, CA Wheat, LJ
Citation: Am. Le Monte et al., DNA fingerprinting of serial Candida albicans isolates obtained during itraconazole prophylaxis in patients with AIDS, MED MYCOL, 39(2), 2001, pp. 207-213
Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy
Authors: Pappas, PG Perfect, JR Cloud, GA Larsen, RA Pankey, GA Lancaster, DJ Henderson, H Kauffman, CA Haas, DW Saccente, M Hamill, RJ Holloway, MS Warren, RM Dismukes, WE
Citation: Pg. Pappas et al., Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy, CLIN INF D, 33(5), 2001, pp. 690-699
Need for alternative trial designs and evaluation strategies for therapeutic studies of invasive mycoses
Authors: Rex, JH Walsh, TJ Nettleman, M Anaissie, EJ Bennett, JE Bow, EJ Carillo-Munoz, AJ Chavanet, P Cloud, GA Denning, DW de Pauw, BE Edwards, JE Hiemenz, JW Kauffman, CA Lopez-Berestein, G Martino, P Sobel, JD Stevens, DA Sylvester, R Tollemar, J Viscoli, C Viviani, MA Wu, T
Citation: Jh. Rex et al., Need for alternative trial designs and evaluation strategies for therapeutic studies of invasive mycoses, CLIN INF D, 33(1), 2001, pp. 95-106
Phenotypic drug susceptibility testing predicts long-term virologic suppression better than treatment history in patients with human immunodeficiencyvirus infection
Authors: Call, SA Saag, MS Westfall, AO Raper, JL Pham, SV Tolson, JM Hellmann, NS Cloud, GA Johnson, VA
Citation: Sa. Call et al., Phenotypic drug susceptibility testing predicts long-term virologic suppression better than treatment history in patients with human immunodeficiencyvirus infection, J INFEC DIS, 183(3), 2001, pp. 401-408
Does long-term itraconazole prophylaxis result in in vitro azole resistance in mucosal Candida albicans isolates from persons with advanced human immunodeficiency virus infection?
Authors: Goldman, M Cloud, GA Smedema, M LeMonte, A Connolly, P McKinsey, DS Kauffman, CA Moskovitz, B Wheat, LJ
Citation: M. Goldman et al., Does long-term itraconazole prophylaxis result in in vitro azole resistance in mucosal Candida albicans isolates from persons with advanced human immunodeficiency virus infection?, ANTIM AG CH, 44(6), 2000, pp. 1585-1587
Comparison of oral fluconazole and itraconazole for progressive, nonmeningeal coccidioidomycosis - A randomized, double-blind trial
Authors: Galgiani, JN Catanzaro, A Cloud, GA Johnson, RH Williams, PL Mirels, LF Nassar, F Lutz, JE Stevens, DA Sharkey, PK Singh, VR Larsen, RA Delgado, KL Flanigan, C Rinaldi, MG
Citation: Jn. Galgiani et al., Comparison of oral fluconazole and itraconazole for progressive, nonmeningeal coccidioidomycosis - A randomized, double-blind trial, ANN INT MED, 133(9), 2000, pp. 676-686
Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: Randomized, placebo-controlled, double-blind study
Authors: McKinsey, DS Wheat, LJ Cloud, GA Pierce, M Black, JR Bamberger, DM Goldman, M Thomas, CJ Gutsch, HM Moskovitz, B Dismukes, WE Kauffman, CA
Citation: Ds. Mckinsey et al., Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: Randomized, placebo-controlled, double-blind study, CLIN INF D, 28(5), 1999, pp. 1049-1056
A comparison of itraconazole versus fluconazole as maintenance therapy forAIDS-associated cryptococcal meningitis
Authors: Saag, MS Cloud, GA Graybill, JR Sobel, JD Tuazon, CU Johnson, PC Fessel, WJ Moskovitz, BL Wiesinger, B Cosmatos, D Riser, L Thomas, C Hafner, R Dismukes, WE
Citation: Ms. Saag et al., A comparison of itraconazole versus fluconazole as maintenance therapy forAIDS-associated cryptococcal meningitis, CLIN INF D, 28(2), 1999, pp. 291-296
Risultati: 1-8 |